Pegasus Asset Management, Inc. Pfizer Inc Transaction History

Pegasus Asset Management, Inc.

$321 Million
Q2 2024

A detailed history of Pegasus Asset Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Pegasus Asset Management, Inc. holds 13,612 shares of PFE stock, worth $403,731. This represents 0.12% of its overall portfolio holdings.

Number of Shares

13,612

Previous 13,612 -0.0%

Holding current value

$403,731

Previous $377,000 0.8%

% of portfolio

0.12%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$25.89 - $29.73 $6,084 - $6,986	-235 Reduced 1.7%	13,612 $377,000
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $9,093 - $11,811	-348 Reduced 2.45%	13,847 $398,000
Q3 2023 Nov 02, 2023	SELL	$32.09 - $37.51 $42,134 - $49,250	-1,313 Reduced 8.47%	14,195 $470,000
Q2 2023 Aug 01, 2023	SELL	$36.12 - $41.79 $2,709 - $3,134	-75 Reduced 0.48%	15,508 $568,000
Q1 2023 Apr 21, 2023	SELL	$39.39 - $51.28 $787 - $1,025	-20 Reduced 0.13%	15,583 $635,000
Q4 2022 Jan 25, 2023	SELL	$41.75 - $54.5 $14,195 - $18,530	-340 Reduced 2.13%	15,603 $0
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $549 - $680	-12 Reduced 0.08%	15,943 $825,000
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $495 - $735	12 Added 0.08%	15,955 $942,000
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $39,853 - $44,946	1,190 Added 8.07%	15,943 $578,000
Q4 2020 Jan 15, 2021	BUY	$33.47 - $42.56 $2,711 - $3,447	81 Added 0.55%	14,753 $543,000
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $12,048 - $14,616	-400 Reduced 2.65%	14,672 $480,000
Q1 2020 Apr 27, 2020	SELL	$27.03 - $38.62 $21,326 - $30,471	-789 Reduced 4.97%	15,072 $491,000
Q4 2019 Jan 22, 2020	BUY	$32.92 - $37.36 $6,221 - $7,061	189 Added 1.21%	15,861 $621,000
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $94,221 - $122,177	-2,900 Reduced 15.61%	15,672 $563,000
Q2 2019 Aug 05, 2019	SELL	$36.98 - $41.52 $50,958 - $57,214	-1,378 Reduced 6.91%	18,572 $805,000
Q1 2019 Apr 24, 2019	SELL	$37.5 - $41.2 $18,750 - $20,600	-500 Reduced 2.44%	19,950 $847,000
Q3 2018 Nov 05, 2018	SELL	$34.47 - $41.81 $29,299 - $35,538	-850 Reduced 3.99%	20,450 $901,000
Q2 2018 Jul 27, 2018	SELL	$32.98 - $35.16 $32,980 - $35,160	-1,000 Reduced 4.48%	21,300 $773,000
Q1 2018 May 01, 2018	SELL	$31.91 - $37.02 $23,198 - $26,913	-727 Reduced 3.16%	22,300 $791,000
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $765,878 - $812,622	23,027	23,027 $834,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Asset Management, Inc. with notifications on news.

Account

Pegasus Asset Management, Inc. Pfizer Inc Transaction History